Deep-cultivated "Belt and Road" emerging markets China's pharmaceutical enterprises have achieved remarkable results

The implementation of the "Belt and Road" initiative provides a new historical opportunity to promote the internationalization level of China's pharmaceutical industryAccording to new data released by the China Chamber of Commerce for Imports and Exports of Medical and Health Products, in 2019, China's pharmaceutical enterprises exported 22.306 billion U.Sdollars to the Belt and Road region and the national market, an increase of 21.63 percent, 7 percent higher than the global average, accounting for 29.1 percent of global exports
In addition, according to Chinese customs statistics, in 2019, China's total imports and exports of medical and health products increased by 26.85 percent year-on-year to US$145.691 billionAmong them, exports grew by 14.6 per cent to $73.83 billion, imports increased by 42.5 per cent to $71.861 billion and the external trade surplus was $1.97 billion, a decrease of 85.92 per cent
Industry said that China's pharmaceutical enterprises deeply ploughed "belt and road" emerging market results are significant, is entering the harvest periodIn addition, the construction of the Belt and Road has played an important role in promoting greater balance, inclusiveness and sustainable development of the global pharmaceutical industry while promoting diversification of the pharmaceutical trade, and has also enabled more and more countries to reap dividends
For the pharmaceutical industry to go out, some enterprises said that the current pharmaceutical industry is in the stage of self-improvement and standardized development, but the future is bound to achieve internationalization, not only the internationalization of technology, including the introduction of technology, the introduction of end products, as well as overseas investment layoutIn his view, with the continuous improvement of policies and regulations, as well as the overall quality of our pharmaceutical industry, in the future "Belt and Road" in-depth cooperation in the process of internationalization, two-way interaction of technology, talent training and management, overseas sales network construction and layout, etc., will contain huge development opportunitiesAnd with the "Belt and Road" construction gradually into a better situation, the future with the "Belt and Road" along the country and region cooperation will also have more flexible, international combination of ways, these will further accelerate the pace of internationalization of the pharmaceutical industry
It can be seen that the Belt and Road Initiative provides a historic opportunity for international cooperation between domestic enterprises and emerging market countriesIt is understood that the huge population base of emerging markets, huge market capacity, low drug self-sufficiency rate, high import dependence, coupled with the "Belt and Road" free trade agreement, both domestic pharmaceutical enterprises in emerging markets to carry out health care cooperation solid foundation
The industry said that the expansion of the "Belt and Road" market can help domestic pharmaceutical companies to solve some of the excess capacity, do large-scale, and gradually grow into a global large-scale pharmaceutical enterprisesThis is also in line with the expansion trajectory of pharmaceutical companies from local, regional and global supply
According to statistics, by the end of January 2020, China had signed 200 cooperation documents with 138 countries and 30 international organizationsIncluding Neusoft Medical, Colum pharmaceutical and other enterprises are actively layout of the "Belt and Road" market For example, Neusoft Medical has cooperated in more than 50 "Belt and Road" countries and regions, representing more than 80%, and Kanghong Pharmaceuticals has set up the Belt and Road Project Office to focus on the development of "Belt and Road" markets along the route
In addition, it is understood that, as the people's heart and people's "health messenger", Chinese medicine is taking advantage of the "Belt and Road" construction of the spring breeze to the world In recent years, Luzhou has actively participated in the construction of the Belt and Road, and has continuously strengthened the foreign cooperation and exchangeof of Chinese medicine industry trade, and promoted the modern Chinese medicine industry to the world.